{
    "clinical_study": {
        "@rank": "78984", 
        "arm_group": [
            {
                "arm_group_label": "30 ml", 
                "arm_group_type": "Experimental", 
                "description": "30 ml ropivacaine 0.1%, single bolus"
            }, 
            {
                "arm_group_label": "10 ml", 
                "arm_group_type": "Experimental", 
                "description": "10 ml 0.1% ropivacaine, single bolus"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate whether reducing the volume (30 versus 10 ml) ropivacaine injected can reduce\n      the number of subjects with impaired muscle strength following adductor canal block. We\n      hypothesized that adductor canal block with 10 ml 0.1% ropivacaine preserves quadriceps\n      strength compared with an adductor canal block with 30 ml."
        }, 
        "brief_title": "Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Muscle Strength", 
            "Healthy Volunteers"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-30 years\n\n          -  Men\n\n          -  ASA 1\n\n          -  Body Mass Index 18-25\n\n        Exclusion Criteria:\n\n          -  Allergy to study medication\n\n          -  Earlier trauma or surgery to the lower limb\n\n          -  Diabetes Mellitus"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981746", 
            "org_study_id": "SM2-PJ-13"
        }, 
        "intervention": {
            "arm_group_label": [
                "30 ml", 
                "10 ml"
            ], 
            "description": "US-guided adductor canal block", 
            "intervention_name": "Adductor canal block with ropivacaine 0.1%", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "adductor canal block", 
            "healthy volunteers", 
            "US-guided peripheral nerve block", 
            "lower limb"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers", 
        "overall_official": {
            "affiliation": "Rigshospitalet, Denmark", 
            "last_name": "Pia Jaeger, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: The Regional Committee on Biomedical Research Ethics", 
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Danish Medicines Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The difference between the two volumes in number of subjects experiencing a reduction in quadriceps muscle strength by more than 25% from baseline in two consecutive assessments.", 
            "measure": "Number of subjects with reduced quadriceps strength", 
            "safety_issue": "No", 
            "time_frame": "0.5 to 6 hours post block"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981746"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Pia Jaeger", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The difference between the two volumes in maximum voluntary isometric contraction (MVIC) of the quadriceps muscle, assessed as percentage of the baseline value.", 
                "measure": "Quadriceps strength in percentage of baseline", 
                "safety_issue": "No", 
                "time_frame": "2, 3 and 4 hours post block"
            }, 
            {
                "description": "The difference between the two volumes in maximum voluntary isometric contraction (MVIC) of the quadriceps muscle calculated as \"area under the curve\" (AUC)", 
                "measure": "Quadriceps strength calculated as AUC", 
                "safety_issue": "No", 
                "time_frame": "30 minutes to 6 hours post block"
            }, 
            {
                "description": "The difference between the pre block value and the post block value in the modified 30-second Chair Stand test performed on one leg, between the two volumes.", 
                "measure": "Modified 30-second Chair Stand test", 
                "safety_issue": "No", 
                "time_frame": "2 and 4 hours post block"
            }, 
            {
                "description": "The difference between the two volumes in VAS pain score during warmth stimulation.", 
                "measure": "VAS pain scores during warmth stimulation", 
                "safety_issue": "No", 
                "time_frame": "Mean value for the periode 30 minutes - 6 hours post block"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}